NRC Health Statistics
Total Valuation
NRC Health has a market cap or net worth of $462.90 million. The enterprise value is $538.39 million.
| Market Cap | 462.90M |
| Enterprise Value | 538.39M |
Important Dates
The next estimated earnings date is Monday, July 27, 2026, after market close.
| Earnings Date | Jul 27, 2026 |
| Ex-Dividend Date | Jun 26, 2026 |
Share Statistics
NRC Health has 22.54 million shares outstanding. The number of shares has decreased by -5.81% in one year.
| Current Share Class | 22.54M |
| Shares Outstanding | 22.54M |
| Shares Change (YoY) | -5.81% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 45.72% |
| Owned by Institutions (%) | 50.18% |
| Float | 12.23M |
Valuation Ratios
The trailing PE ratio is 53.34 and the forward PE ratio is 24.45.
| PE Ratio | 53.34 |
| Forward PE | 24.45 |
| PS Ratio | 3.34 |
| Forward PS | 3.21 |
| PB Ratio | 34.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 26.56 |
| P/OCF Ratio | 17.15 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.56, with an EV/FCF ratio of 30.89.
| EV / Earnings | 62.65 |
| EV / Sales | 3.88 |
| EV / EBITDA | 15.56 |
| EV / EBIT | 20.43 |
| EV / FCF | 30.89 |
Financial Position
The company has a current ratio of 0.52, with a Debt / Equity ratio of 5.78.
| Current Ratio | 0.52 |
| Quick Ratio | 0.36 |
| Debt / Equity | 5.78 |
| Debt / EBITDA | 2.26 |
| Debt / FCF | 4.48 |
| Interest Coverage | 5.15 |
Financial Efficiency
Return on equity (ROE) is 41.86% and return on invested capital (ROIC) is 18.34%.
| Return on Equity (ROE) | 41.86% |
| Return on Assets (ROA) | 12.21% |
| Return on Invested Capital (ROIC) | 18.34% |
| Return on Capital Employed (ROCE) | 27.42% |
| Weighted Average Cost of Capital (WACC) | 6.10% |
| Revenue Per Employee | $388,353 |
| Profits Per Employee | $24,073 |
| Employee Count | 357 |
| Asset Turnover | 1.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NRC Health has paid $5.47 million in taxes.
| Income Tax | 5.47M |
| Effective Tax Rate | 37.69% |
Stock Price Statistics
The stock price has increased by +19.14% in the last 52 weeks. The beta is 0.40, so NRC Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +19.14% |
| 50-Day Moving Average | 18.67 |
| 200-Day Moving Average | 16.65 |
| Relative Strength Index (RSI) | 59.07 |
| Average Volume (20 Days) | 171,325 |
Short Selling Information
The latest short interest is 466,579, so 2.07% of the outstanding shares have been sold short.
| Short Interest | 466,579 |
| Short Previous Month | 456,739 |
| Short % of Shares Out | 2.07% |
| Short % of Float | 3.81% |
| Short Ratio (days to cover) | 3.97 |
Income Statement
In the last 12 months, NRC Health had revenue of $138.64 million and earned $8.59 million in profits. Earnings per share was $0.39.
| Revenue | 138.64M |
| Gross Profit | 85.68M |
| Operating Income | 26.35M |
| Pretax Income | 14.50M |
| Net Income | 8.59M |
| EBITDA | 34.60M |
| EBIT | 26.35M |
| Earnings Per Share (EPS) | $0.39 |
Balance Sheet
The company has $2.55 million in cash and $78.03 million in debt, with a net cash position of -$75.49 million or -$3.35 per share.
| Cash & Cash Equivalents | 2.55M |
| Total Debt | 78.03M |
| Net Cash | -75.49M |
| Net Cash Per Share | -$3.35 |
| Equity (Book Value) | 13.50M |
| Book Value Per Share | 0.60 |
| Working Capital | -18.49M |
Cash Flow
In the last 12 months, operating cash flow was $26.98 million and capital expenditures -$9.55 million, giving a free cash flow of $17.43 million.
| Operating Cash Flow | 26.98M |
| Capital Expenditures | -9.55M |
| Depreciation & Amortization | 8.25M |
| Net Borrowing | 12.70M |
| Free Cash Flow | 17.43M |
| FCF Per Share | $0.77 |
Margins
Gross margin is 61.80%, with operating and profit margins of 19.01% and 6.52%.
| Gross Margin | 61.80% |
| Operating Margin | 19.01% |
| Pretax Margin | 10.46% |
| Profit Margin | 6.52% |
| EBITDA Margin | 24.96% |
| EBIT Margin | 19.01% |
| FCF Margin | 12.57% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 3.12%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 3.12% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 155.81% |
| Buyback Yield | 5.81% |
| Shareholder Yield | 8.93% |
| Earnings Yield | 1.86% |
| FCF Yield | 3.77% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NRC Health has an Altman Z-Score of 3.04 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.04 |
| Piotroski F-Score | 5 |